Neudle.com: blacks

Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997

Intracerebral Hemorrhage in Blacks, Risk Factors, Subtypes, and Outcome
Stroke 28:961-964, Qureshi,A.I.,et al, 1997

Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997

Ticlopidine and Thrombotic Thrombocytopenic Purpura
NEJM 337:1245, Kupfer,Y.&Tessler,S., 1997

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

Does Daily Aspirin Diminish Severity of First-Ever Stroke
Arch Neurol 54:1369-1371, Karepov,V.,et al, 1997

Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996

Ethnic Differences in Carotid Wall Thickness:The Insulin Resistance Atherosclerosis Study
Stroke 27:1744-1749, D'Agostino,R.B.,et al, 1996

Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996

Human T-Cell Lymphotrophic Virus Type II-Associated Myelopathy:Clinical and Immunologic Profiles
Ann Neurol 40:714-723, Lenky,T.J.,et al, 1996

Differential Effect of Aspirin Vs Warfarin on Clinical Stroke Types in Pts with Atrial Fibrillation
Neurol 46:238-240, Miller,V.T.,et al, 1996

Cerebellar Hemorrhagic Infarction
Neurol 46:346-349, Chaves,C.J.,et al, 1996

Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996

The Relation Between Fish Consump & Stroke Incidence, NHANES I Epidemiol Study
Arch Int Med 156:537-542, Gillum,R.F.,et al, 1996

MRI In Patients with General Paresis
Neuroradiology 38:120-123, Zifko,U.,et al, 1996

Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996

Aspirin Wars-The Optimal Dose of Aspirin to Prevent Stroke
Stroke 27:585-587, Hart,R.G.&Harrison,M.J.G., 1996

Aspirin Dose in Stroke Prevention-Beautiful Hypotheses Slain by Ugly Facts
Stroke 27:588-592, Barnett,H.J.M.,et al, 1996

US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996

Spontaneous Bilateral Subdural Hematomas Associated with Chronic Ginkgo Biloba Ingestion
Neurol 46:1775-1776, Rowin,J.&Lewis,S., 1996

An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996

Tuberculous Meningitis Among Adults with and without HIV Infection
Arch Int med 156:1710-1716, Yechoor,V.K.,et al, 1996

Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996

Race and Sex Differences in the Distribution of Cerebral Atherosclerosis
Stroke 27:1974-1980, Wityk,R.J.,et al, 1996

A Randomised
Blinded Trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) , CAPRIE S, eerimte,Lancet 348:1329-1339,1996., 1996

Antiplatelet Treatment in Elderly People with Transient Ischaemic Attacks or Ischaemic Strokes
BMJ 310:25-26, Sivenius,J.,et al, 1995

Early Anticoagulation After Large Cerebral Embolic Infarction:A Safety Study
Neurol 45:861-865, Chamorro,A.,et al, 1995

The Warfarin-Aspirin Symptomatic Intracranial Disease Study
Neurol 45:1488-1493, Chimowitz,M.I.,et al, 1995

Determinants of Black-White Differences in the Risk of Cerebral Infarction
Arch Int Med 155:1319-1324, Giles,W.H.,et al, 1995

Race-ethnic Diff in Stroke Risk Factors Among Hosp Pts with Cerebral Infarction:The No Manhattan Stroke Study
Neurol 45:659-663, Sacco,R.L.,et al, 1995

Epidemiology of Carotid Endarterectomy and Cerebral Arteriography in the United States
Stroke 26:1724-1728, Gillum,R.F., 1995

Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995

Lack of Effect of Aspirin in Asymptomatic Patients with Carotid Bruits and Substantial Carotid Narrowing
Ann Int Med 123:649-655, Cote,R.,et al, 1995

A 79-Year Old Musician with Asymptomatic Carotid Artery Disease
JAMA 274:1383-1389, Caplan,L.R., 1995

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
NEJM 333:1588-1593, Kay,R.,et al, 1995

Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995

Stroke in Young Black Patients:Risk Factors, Subtypes, & Prognosis
Stroke 26:1995-1998, Qureshi,A.I.,et al, 1995

Predictors of Early Deterioration and Mortality in Black Americans with Spontaneous Intracerebral Hemorrhage
Stroke 26:1764-1767, Qureshi,A.I.,et al, 1995

Systemic Sclerosis Sine Scleroderma:An Unusual Presentation in Scleroderma Renal Crisis
J Rheumatol 22:557-560, Molina,J.F.,et al, 1995

Stroke Prevention Therapies and Management of Patient Subgroups
Neurol 45:S19-S24, Raps,E.C.&Galetta,S.L., 1995

Drugs and Surgery in the Prevention of Ischemic Stroke
NEJM 332:238-248, Barnett,H.J.M.,et al, 1995

Race-Ethnicity and Determinants of Intracranial Atherosclerotic Cerebral Infarction:The Northern Manhattan Stroke Study
Stroke 26:14-20, Sacco,R.L.,et al, 1995

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Racial Disparities in Severity of Cerebrovascular Events
Stroke 25:2126-2131, Kuhlemeier,K.V.&Stiens,S.A., 1994

Ethnic Differences in Stroke Mortality Between Non-Hispanic Whites, Hispanic Whites, & Blacks:National Long Mort Study
Stroke 25:2120-2125, Howard,G.,et al, 1994

Warfarin Versus Aspirin for Prevention of Thromboembolism in Atrial Fibrillation:SPAF II Study
SPAF-II Investigators, Lancet 343:687-691, 683994., , 1994

Showing articles 600 to 650 of 856 << Previous Next >>